CA Patent

CA2473412A1 — Liquid pharmaceutical injectable formulation of octreotide

Assigned to LABORATOIRES OMEGA LTEE · Expires 2006-01-08 · 20y expired

What this patent protects

A liquid pharmaceutical composition of pH between about 3 and about 9 comprising (a) octreotide (salt or base) of concentration from about 0.001 to about 5 g/L (under free-peptide form); (b) a suitable inorganic or organic buffer system; (c) in water; (d) in an appropriate contai…

USPTO Abstract

A liquid pharmaceutical composition of pH between about 3 and about 9 comprising (a) octreotide (salt or base) of concentration from about 0.001 to about 5 g/L (under free-peptide form); (b) a suitable inorganic or organic buffer system; (c) in water; (d) in an appropriate container. The packaging material could be treated glass container, or constituted of anoth er appropriate material with or without an elastomeric stopper.

Drugs covered by this patent

Patent Metadata

Patent number
CA2473412A1
Jurisdiction
CA
Classification
—
Expires
2006-01-08
Drug substance claim
No
Drug product claim
No
Assignee
LABORATOIRES OMEGA LTEE
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.